Critical Therapeutics Reports Third Quarter 2006 Financial Results.
Business Wire › November 09, 2006
Linked as:
Extract
Critical Therapeutics Reports Third Quarter 2006 Financial Results.
LEXINGTON, Mass. -- Critical Therapeutics, Inc. (Nasdaq: CRTX) today reported financial results for the quarter ended September 30, 2006. For the three months ended September 30, 2006, the Company posted a net loss of $8.9 million, or $0.26 per share, based on approximately 34.3 million weighted average shares outstanding. This compares with a net loss of $14.0 million, or $0.41 per share, for the same period in 2005, based on approximately 34.0 million weighted average shares outstanding. Financial results for 2006 reflect the adoption of Statement of Financial Accounting Standards No. 123R (SFAS 123R), related to employee stock-based compensation expense.
Product sales of ZYFLO[R] (zileuton tablets), net of returns, increased approximately four percent over the second quarter of 2006, accounting for approximatel...See the full content of this document
Sponsored links
